205 related articles for article (PubMed ID: 38281962)
21. Decoding the Immune Microenvironment of Clear Cell Renal Cell Carcinoma by Single-Cell Profiling to Aid Immunotherapy.
Liu J; Xu J; Zhang T; Xu K; Bao P; Zhang Z; Xue K; He R; Ma L; Wang Y
Front Immunol; 2022; 13():791158. PubMed ID: 35812372
[TBL] [Abstract][Full Text] [Related]
22. Clear Cell Type A and B Molecular Subtypes in Metastatic Clear Cell Renal Cell Carcinoma: Tumor Heterogeneity and Aggressiveness.
Serie DJ; Joseph RW; Cheville JC; Ho TH; Parasramka M; Hilton T; Thompson RH; Leibovich BC; Parker AS; Eckel-Passow JE
Eur Urol; 2017 Jun; 71(6):979-985. PubMed ID: 27899233
[TBL] [Abstract][Full Text] [Related]
23. RP11-367G18.1 V2 enhances clear cell renal cell carcinoma progression via induction of epithelial-mesenchymal transition.
Shao IH; Peng PH; Wu HH; Chen JL; Lai JC; Chang JS; Wu HT; Wu KJ; Pang ST; Hsu KW
Cancer Med; 2023 Apr; 12(8):9788-9801. PubMed ID: 36847128
[TBL] [Abstract][Full Text] [Related]
24. Progressive immune dysfunction with advancing disease stage in renal cell carcinoma.
Braun DA; Street K; Burke KP; Cookmeyer DL; Denize T; Pedersen CB; Gohil SH; Schindler N; Pomerance L; Hirsch L; Bakouny Z; Hou Y; Forman J; Huang T; Li S; Cui A; Keskin DB; Steinharter J; Bouchard G; Sun M; Pimenta EM; Xu W; Mahoney KM; McGregor BA; Hirsch MS; Chang SL; Livak KJ; McDermott DF; Shukla SA; Olsen LR; Signoretti S; Sharpe AH; Irizarry RA; Choueiri TK; Wu CJ
Cancer Cell; 2021 May; 39(5):632-648.e8. PubMed ID: 33711273
[TBL] [Abstract][Full Text] [Related]
25. Upregulation of CENPM is associated with poor clinical outcome and suppression of immune profile in clear cell renal cell carcinoma.
Zhang ZC; Liu YF; Xi P; Nie YC; Sun T; Gong BB
Hereditas; 2023 Jan; 160(1):1. PubMed ID: 36635779
[TBL] [Abstract][Full Text] [Related]
26. "Renal Cell Carcinoma With Leiomyomatous Stroma" Harbor Somatic Mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic Tumors Supports a Distinct Entity.
Shah RB; Stohr BA; Tu ZJ; Gao Y; Przybycin CG; Nguyen J; Cox RM; Rashid-Kolvear F; Weindel MD; Farkas DH; Trpkov K; McKenney JK
Am J Surg Pathol; 2020 May; 44(5):571-581. PubMed ID: 31850909
[TBL] [Abstract][Full Text] [Related]
27. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
28. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
29. Kinase Gene Expression Profiling of Metastatic Clear Cell Renal Cell Carcinoma Tissue Identifies Potential New Therapeutic Targets.
Ghatalia P; Yang ES; Lasseigne BN; Ramaker RC; Cooper SJ; Chen D; Sudarshan S; Wei S; Guru AS; Zhao A; Cooper T; Della Manna DL; Naik G; Myers RM; Sonpavde G
PLoS One; 2016; 11(8):e0160924. PubMed ID: 27574806
[TBL] [Abstract][Full Text] [Related]
30. The dynamic tumor-stromal crosstalk: implications of 'stromal-hot' tumors in the process of epithelial-mesenchymal transition in breast cancer.
Mavatkar AD; Naidu CM; Prabhu JS; Nair MG
Mol Biol Rep; 2023 Jun; 50(6):5379-5393. PubMed ID: 37046108
[TBL] [Abstract][Full Text] [Related]
31. Calcium phosphate scaffolds with defined interconnecting channel structure provide a mimetic 3D niche for bone marrow metastasized tumor cell growth.
Aveic S; Davtalab R; Vogt M; Weber M; Buttler P; Tonini GP; Fischer H
Acta Biomater; 2019 Apr; 88():527-539. PubMed ID: 30797105
[TBL] [Abstract][Full Text] [Related]
32. Cancer-associated fibroblasts in renal cell carcinoma: implication in prognosis and resistance to anti-angiogenic therapy.
Ambrosetti D; Coutts M; Paoli C; Durand M; Borchiellini D; Montemagno C; Rastoin O; Borderie A; Grepin R; Rioux-Leclercq N; Bernhard JC; Pagès G; Dufies M
BJU Int; 2022 Jan; 129(1):80-92. PubMed ID: 34107167
[TBL] [Abstract][Full Text] [Related]
33. Differential gene expression profiling of matched primary renal cell carcinoma and metastases reveals upregulation of extracellular matrix genes.
Ho TH; Serie DJ; Parasramka M; Cheville JC; Bot BM; Tan W; Wang L; Joseph RW; Hilton T; Leibovich BC; Parker AS; Eckel-Passow JE
Ann Oncol; 2017 Mar; 28(3):604-610. PubMed ID: 27993815
[TBL] [Abstract][Full Text] [Related]
34. Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma.
Zhang M; Yang H; Wan L; Wang Z; Wang H; Ge C; Liu Y; Hao Y; Zhang D; Shi G; Gong Y; Ni Y; Wang C; Zhang Y; Xi J; Wang S; Shi L; Zhang L; Yue W; Pei X; Liu B; Yan X
J Hepatol; 2020 Nov; 73(5):1118-1130. PubMed ID: 32505533
[TBL] [Abstract][Full Text] [Related]
35. Clear Cell Renal Cell Carcinoma is linked to Epithelial-to-Mesenchymal Transition and to Fibrosis.
Landolt L; Eikrem Ø; Strauss P; Scherer A; Lovett DH; Beisland C; Finne K; Osman T; Ibrahim MM; Gausdal G; Ahmed L; Lorens JB; Thiery JP; Tan TZ; Sekulic M; Marti HP
Physiol Rep; 2017 Jun; 5(11):. PubMed ID: 28596300
[TBL] [Abstract][Full Text] [Related]
36. Molecular Characterization of Clear Cell Renal Cell Carcinoma Reveals Prognostic Significance of Epithelial-mesenchymal Transition Gene Expression Signature.
Nallandhighal S; Vince R; Karim R; Groves S; Stangl-Kremser J; Russell C; Hu K; Pham T; Cani AK; Liu CJ; Zaslavsky A; Mehra R; Cieslik M; Morgan TM; Palapattu GS; Udager AM; Salami SS
Eur Urol Oncol; 2022 Feb; 5(1):92-99. PubMed ID: 34840106
[TBL] [Abstract][Full Text] [Related]
37. The metastatic niche and stromal progression.
Sleeman JP
Cancer Metastasis Rev; 2012 Dec; 31(3-4):429-40. PubMed ID: 22699312
[TBL] [Abstract][Full Text] [Related]
38. Inflammatory Components of the Thyroid Cancer Microenvironment: An Avenue for Identification of Novel Biomarkers.
Jarboe T; Tuli NY; Chakraborty S; Maniyar RR; DeSouza N; Xiu-Min Li ; Moscatello A; Geliebter J; Tiwari RK
Adv Exp Med Biol; 2021; 1350():1-31. PubMed ID: 34888842
[TBL] [Abstract][Full Text] [Related]
39. Characterization of papillary and clear cell renal cell carcinoma through imaging mass cytometry reveals distinct immunologic profiles.
Govindarajan A; Salgia NJ; Li H; Castro DV; Mirzapoiazova T; Armstrong B; Zhao D; Mercier BD; Dizman N; Chawla N; Zengin Z; Meza L; Tripathi N; Sayegh N; Chehrazi-Raffle A; Tripathi A; Pal SK
Front Immunol; 2023; 14():1182581. PubMed ID: 37638025
[TBL] [Abstract][Full Text] [Related]
40. Disruption of crosstalk between mesenchymal stromal and tumor cells in bone marrow as a therapeutic target to prevent metastatic bone disease.
Gordon JA; Lisle JW; Alman BA; Lian JB
J Cell Physiol; 2014 Dec; 229(12):1884-6. PubMed ID: 24905746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
